Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s00702-006-0485-7.

Title:
Cerebrospinal fluid diagnostic markers correlate with lower plasma copper and ceruloplasmin in patients with Alzheimer’s disease | Journal of Neural Transmission
Description:
Increasing evidence links Alzheimer’s disease (AD) with misbalanced Cu homeostasis. Recently, we have shown that dietary Cu supplementation in a transgenic mouse model for AD increases bioavailable brain Cu levels, restores Cu, Zn-super oxide-1 activity, prevents premature death, and lowers Aβ levels. In the present report we investigated AD patients with normal levels of Aβ42, Tau and Phospho-Tau in the cerebrospinal fluid (CSF) in comparison with AD patients exhibiting aberrant levels in these CSF biomarkers. The influence of these cerebrospinal fluid (CSF) diagnostic markers with primary dependent variables blood Cu, Zn and ceruloplasmin (CB) and secondary with CSF profiles of Cu, Zn and neurotransmitters was determined. Multivariate tests revealed a significant effect of factor diagnostic group (no AD diagnosis in CSF or AD diagnosis in CSF) for variables plasma Cu and CB (F = 4.80; df = 2, 23; p = 0.018). Subsequent univariate tests revealed significantly reduced plasma Cu (−12.7%; F = 7.05; df = 1, 25; p = 0.014) and CB (−14.1%; F = 9.44; df = 1, 24; p = 0.005) levels in patients with aberrant CSF biomarker concentrations. Although only AD patients were included, the reduced plasma Cu and CB levels in patients with a CSF diagnosis of advanced AD supports previous observations that a mild Cu deficiency might contribute to AD progression.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Health & Fitness
  • Science
  • Education

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don’t know how the website earns money.

Some websites aren't about earning revenue; they're built to connect communities or raise awareness. There are numerous motivations behind creating websites. This might be one of them. Link.springer.com might be cashing in, but we can't detect the method they're using.

Keywords {🔍}

article, pubmed, google, scholar, cas, alzheimers, disease, copper, csf, patients, multhaup, cerebrospinal, fluid, levels, biol, amyloid, masters, diagnostic, markers, ceruloplasmin, brain, tau, beyreuther, plasma, bayer, diagnosis, access, chem, jbcm, cappai, protein, privacy, cookies, content, journal, neurology, psychiatry, bush, betaamyloid, information, publish, search, kessler, pajonk, biomarkers, superoxide, dismutase, beta, precursor, sod,

Topics {✒️}

amyloid-precursor-protein secretion biochem month download article/chapter antz wr krause high-performance liquid chromatography muller-tillmanns hh jung nincds-adrda work group disease amyloid-beta opposes zn-super oxide-1 activity multivariate tests revealed tanzi ai bush ruppert cl masters full article pdf copper–zinc chelator markedly beyreuther cl masters amyloid precursor protein reduced plasma cu human cerebrospinal fluid neural transmission aims cappai cl masters beher cl masters cappai ta bayer cerebrospinal fluid ratio zheng ai bush variables plasma cu dyal2sxmsfsntq%3d%3d 10 dyak2cxltfklug%3d%3d 10 dyak2sxisforta%3d%3d 10 dyak1mzktvchtw%3d%3d 10 dyak3c3gtfoisq%3d%3d 10 dietary cu supplementation factor diagnostic group privacy choices/manage cookies dc%2bd2mxjsl2hsry%3d 10 dc%2bd3cxmtfyrsls%3d 10 dc%2bd3sxjsvkmsbo%3d 10 dc%2bd3sxms1altbw%3d 10 dc%2bd3cxlvveqsbk%3d 10 dc%2bd3sxpsfgitbg%3d 10 dc%2bd3sxis12nsb8%3d 10 dc%2bd3mxkvfsksbw%3d 10 dc%2bd2cxhtv2ksly%3d 10 dc%2bd38xosl2ntlg%3d 10 dc%2bd3mxisvcms70%3d 10 dc%2bd3sxpsfgitbk%3d 10 cognitive decline correlates cassetta pm rossini combined diagnostic models cerebrospinal fluid alzheimer low plasma concentrations volitakis fw fraser

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Cerebrospinal fluid diagnostic markers correlate with lower plasma copper and ceruloplasmin in patients with Alzheimer’s disease
         description:Increasing evidence links Alzheimer’s disease (AD) with misbalanced Cu homeostasis. Recently, we have shown that dietary Cu supplementation in a transgenic mouse model for AD increases bioavailable brain Cu levels, restores Cu, Zn-super oxide-1 activity, prevents premature death, and lowers Aβ levels. In the present report we investigated AD patients with normal levels of Aβ42, Tau and Phospho-Tau in the cerebrospinal fluid (CSF) in comparison with AD patients exhibiting aberrant levels in these CSF biomarkers. The influence of these cerebrospinal fluid (CSF) diagnostic markers with primary dependent variables blood Cu, Zn and ceruloplasmin (CB) and secondary with CSF profiles of Cu, Zn and neurotransmitters was determined. Multivariate tests revealed a significant effect of factor diagnostic group (no AD diagnosis in CSF or AD diagnosis in CSF) for variables plasma Cu and CB (F = 4.80; df = 2, 23; p = 0.018). Subsequent univariate tests revealed significantly reduced plasma Cu (−12.7%; F = 7.05; df = 1, 25; p = 0.014) and CB (−14.1%; F = 9.44; df = 1, 24; p = 0.005) levels in patients with aberrant CSF biomarker concentrations. Although only AD patients were included, the reduced plasma Cu and CB levels in patients with a CSF diagnosis of advanced AD supports previous observations that a mild Cu deficiency might contribute to AD progression.
         datePublished:2006-06-01T00:00:00Z
         dateModified:2006-06-01T00:00:00Z
         pageStart:1763
         pageEnd:1769
         sameAs:https://doi.org/10.1007/s00702-006-0485-7
         keywords:
            Keywords: CSF, copper, Alzheimer’s disease
            Neurology
            Psychiatry
            Neurosciences
         image:
         isPartOf:
            name:Journal of Neural Transmission
            issn:
               1435-1463
               0300-9564
            volumeNumber:113
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:H. Kessler
               affiliation:
                     name:Saarland University
                     address:
                        name:Department of Psychiatry and Psychotherapy, Saarland University, Homburg/Saar, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:F.-G. Pajonk
               affiliation:
                     name:Saarland University
                     address:
                        name:Department of Psychiatry and Psychotherapy, Saarland University, Homburg/Saar, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:P. Meisser
               affiliation:
                     name:Saarland University
                     address:
                        name:Department of Psychiatry and Psychotherapy, Saarland University, Homburg/Saar, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:T. Schneider-Axmann
               affiliation:
                     name:Saarland University
                     address:
                        name:Department of Psychiatry and Psychotherapy, Saarland University, Homburg/Saar, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:K.-H. Hoffmann
               affiliation:
                     name:Saarland University
                     address:
                        name:Department of Psychiatry and Psychotherapy, Saarland University, Homburg/Saar, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:T. Supprian
               affiliation:
                     name:Saarland University
                     address:
                        name:Department of Psychiatry and Psychotherapy, Saarland University, Homburg/Saar, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:W. Herrmann
               affiliation:
                     name:Saarland University Hospital
                     address:
                        name:Department for Clinical Chemistry, Central Laboratory, Saarland University Hospital, Homburg/Saar, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:R. Obeid
               affiliation:
                     name:Saarland University Hospital
                     address:
                        name:Department for Clinical Chemistry, Central Laboratory, Saarland University Hospital, Homburg/Saar, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:G. Multhaup
               affiliation:
                     name:Free University of Berlin
                     address:
                        name:Institute for Chemistry-Biochemistry, Free University of Berlin, Berlin, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:P. Falkai
               affiliation:
                     name:Saarland University
                     address:
                        name:Department of Psychiatry and Psychotherapy, Saarland University, Homburg/Saar, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:T. A. Bayer
               affiliation:
                     name:Saarland University
                     address:
                        name:Department of Psychiatry and Psychotherapy, Saarland University, Homburg/Saar, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Cerebrospinal fluid diagnostic markers correlate with lower plasma copper and ceruloplasmin in patients with Alzheimer’s disease
      description:Increasing evidence links Alzheimer’s disease (AD) with misbalanced Cu homeostasis. Recently, we have shown that dietary Cu supplementation in a transgenic mouse model for AD increases bioavailable brain Cu levels, restores Cu, Zn-super oxide-1 activity, prevents premature death, and lowers Aβ levels. In the present report we investigated AD patients with normal levels of Aβ42, Tau and Phospho-Tau in the cerebrospinal fluid (CSF) in comparison with AD patients exhibiting aberrant levels in these CSF biomarkers. The influence of these cerebrospinal fluid (CSF) diagnostic markers with primary dependent variables blood Cu, Zn and ceruloplasmin (CB) and secondary with CSF profiles of Cu, Zn and neurotransmitters was determined. Multivariate tests revealed a significant effect of factor diagnostic group (no AD diagnosis in CSF or AD diagnosis in CSF) for variables plasma Cu and CB (F = 4.80; df = 2, 23; p = 0.018). Subsequent univariate tests revealed significantly reduced plasma Cu (−12.7%; F = 7.05; df = 1, 25; p = 0.014) and CB (−14.1%; F = 9.44; df = 1, 24; p = 0.005) levels in patients with aberrant CSF biomarker concentrations. Although only AD patients were included, the reduced plasma Cu and CB levels in patients with a CSF diagnosis of advanced AD supports previous observations that a mild Cu deficiency might contribute to AD progression.
      datePublished:2006-06-01T00:00:00Z
      dateModified:2006-06-01T00:00:00Z
      pageStart:1763
      pageEnd:1769
      sameAs:https://doi.org/10.1007/s00702-006-0485-7
      keywords:
         Keywords: CSF, copper, Alzheimer’s disease
         Neurology
         Psychiatry
         Neurosciences
      image:
      isPartOf:
         name:Journal of Neural Transmission
         issn:
            1435-1463
            0300-9564
         volumeNumber:113
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:H. Kessler
            affiliation:
                  name:Saarland University
                  address:
                     name:Department of Psychiatry and Psychotherapy, Saarland University, Homburg/Saar, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:F.-G. Pajonk
            affiliation:
                  name:Saarland University
                  address:
                     name:Department of Psychiatry and Psychotherapy, Saarland University, Homburg/Saar, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:P. Meisser
            affiliation:
                  name:Saarland University
                  address:
                     name:Department of Psychiatry and Psychotherapy, Saarland University, Homburg/Saar, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:T. Schneider-Axmann
            affiliation:
                  name:Saarland University
                  address:
                     name:Department of Psychiatry and Psychotherapy, Saarland University, Homburg/Saar, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:K.-H. Hoffmann
            affiliation:
                  name:Saarland University
                  address:
                     name:Department of Psychiatry and Psychotherapy, Saarland University, Homburg/Saar, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:T. Supprian
            affiliation:
                  name:Saarland University
                  address:
                     name:Department of Psychiatry and Psychotherapy, Saarland University, Homburg/Saar, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:W. Herrmann
            affiliation:
                  name:Saarland University Hospital
                  address:
                     name:Department for Clinical Chemistry, Central Laboratory, Saarland University Hospital, Homburg/Saar, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:R. Obeid
            affiliation:
                  name:Saarland University Hospital
                  address:
                     name:Department for Clinical Chemistry, Central Laboratory, Saarland University Hospital, Homburg/Saar, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:G. Multhaup
            affiliation:
                  name:Free University of Berlin
                  address:
                     name:Institute for Chemistry-Biochemistry, Free University of Berlin, Berlin, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:P. Falkai
            affiliation:
                  name:Saarland University
                  address:
                     name:Department of Psychiatry and Psychotherapy, Saarland University, Homburg/Saar, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:T. A. Bayer
            affiliation:
                  name:Saarland University
                  address:
                     name:Department of Psychiatry and Psychotherapy, Saarland University, Homburg/Saar, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Journal of Neural Transmission
      issn:
         1435-1463
         0300-9564
      volumeNumber:113
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Saarland University
      address:
         name:Department of Psychiatry and Psychotherapy, Saarland University, Homburg/Saar, Germany
         type:PostalAddress
      name:Saarland University
      address:
         name:Department of Psychiatry and Psychotherapy, Saarland University, Homburg/Saar, Germany
         type:PostalAddress
      name:Saarland University
      address:
         name:Department of Psychiatry and Psychotherapy, Saarland University, Homburg/Saar, Germany
         type:PostalAddress
      name:Saarland University
      address:
         name:Department of Psychiatry and Psychotherapy, Saarland University, Homburg/Saar, Germany
         type:PostalAddress
      name:Saarland University
      address:
         name:Department of Psychiatry and Psychotherapy, Saarland University, Homburg/Saar, Germany
         type:PostalAddress
      name:Saarland University
      address:
         name:Department of Psychiatry and Psychotherapy, Saarland University, Homburg/Saar, Germany
         type:PostalAddress
      name:Saarland University Hospital
      address:
         name:Department for Clinical Chemistry, Central Laboratory, Saarland University Hospital, Homburg/Saar, Germany
         type:PostalAddress
      name:Saarland University Hospital
      address:
         name:Department for Clinical Chemistry, Central Laboratory, Saarland University Hospital, Homburg/Saar, Germany
         type:PostalAddress
      name:Free University of Berlin
      address:
         name:Institute for Chemistry-Biochemistry, Free University of Berlin, Berlin, Germany
         type:PostalAddress
      name:Saarland University
      address:
         name:Department of Psychiatry and Psychotherapy, Saarland University, Homburg/Saar, Germany
         type:PostalAddress
      name:Saarland University
      address:
         name:Department of Psychiatry and Psychotherapy, Saarland University, Homburg/Saar, Germany
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:H. Kessler
      affiliation:
            name:Saarland University
            address:
               name:Department of Psychiatry and Psychotherapy, Saarland University, Homburg/Saar, Germany
               type:PostalAddress
            type:Organization
      name:F.-G. Pajonk
      affiliation:
            name:Saarland University
            address:
               name:Department of Psychiatry and Psychotherapy, Saarland University, Homburg/Saar, Germany
               type:PostalAddress
            type:Organization
      name:P. Meisser
      affiliation:
            name:Saarland University
            address:
               name:Department of Psychiatry and Psychotherapy, Saarland University, Homburg/Saar, Germany
               type:PostalAddress
            type:Organization
      name:T. Schneider-Axmann
      affiliation:
            name:Saarland University
            address:
               name:Department of Psychiatry and Psychotherapy, Saarland University, Homburg/Saar, Germany
               type:PostalAddress
            type:Organization
      name:K.-H. Hoffmann
      affiliation:
            name:Saarland University
            address:
               name:Department of Psychiatry and Psychotherapy, Saarland University, Homburg/Saar, Germany
               type:PostalAddress
            type:Organization
      name:T. Supprian
      affiliation:
            name:Saarland University
            address:
               name:Department of Psychiatry and Psychotherapy, Saarland University, Homburg/Saar, Germany
               type:PostalAddress
            type:Organization
      name:W. Herrmann
      affiliation:
            name:Saarland University Hospital
            address:
               name:Department for Clinical Chemistry, Central Laboratory, Saarland University Hospital, Homburg/Saar, Germany
               type:PostalAddress
            type:Organization
      name:R. Obeid
      affiliation:
            name:Saarland University Hospital
            address:
               name:Department for Clinical Chemistry, Central Laboratory, Saarland University Hospital, Homburg/Saar, Germany
               type:PostalAddress
            type:Organization
      name:G. Multhaup
      affiliation:
            name:Free University of Berlin
            address:
               name:Institute for Chemistry-Biochemistry, Free University of Berlin, Berlin, Germany
               type:PostalAddress
            type:Organization
      name:P. Falkai
      affiliation:
            name:Saarland University
            address:
               name:Department of Psychiatry and Psychotherapy, Saarland University, Homburg/Saar, Germany
               type:PostalAddress
            type:Organization
      name:T. A. Bayer
      affiliation:
            name:Saarland University
            address:
               name:Department of Psychiatry and Psychotherapy, Saarland University, Homburg/Saar, Germany
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Psychiatry and Psychotherapy, Saarland University, Homburg/Saar, Germany
      name:Department of Psychiatry and Psychotherapy, Saarland University, Homburg/Saar, Germany
      name:Department of Psychiatry and Psychotherapy, Saarland University, Homburg/Saar, Germany
      name:Department of Psychiatry and Psychotherapy, Saarland University, Homburg/Saar, Germany
      name:Department of Psychiatry and Psychotherapy, Saarland University, Homburg/Saar, Germany
      name:Department of Psychiatry and Psychotherapy, Saarland University, Homburg/Saar, Germany
      name:Department for Clinical Chemistry, Central Laboratory, Saarland University Hospital, Homburg/Saar, Germany
      name:Department for Clinical Chemistry, Central Laboratory, Saarland University Hospital, Homburg/Saar, Germany
      name:Institute for Chemistry-Biochemistry, Free University of Berlin, Berlin, Germany
      name:Department of Psychiatry and Psychotherapy, Saarland University, Homburg/Saar, Germany
      name:Department of Psychiatry and Psychotherapy, Saarland University, Homburg/Saar, Germany
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(152)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

6.19s.